GlobeNewswire (press release) The preclinical data presented at the conference also show a different profile of vortioxetine compared to fluoxetine and escitalopram (SSRIs) as well as duloxetine (an SNRI), which were not active in these animal models. While animal studies may not ... and more »
GlobeNewswire (press release) The preclinical data presented at the conference also show a different profile of vortioxetine compared to fluoxetine and escitalopram (SSRIs) as well as duloxetine (an SNRI), which were not active in these animal models. While animal studies may not ... and more »
GlobeNewswire (press release) The preclinical data presented at the conference also show a different profile of vortioxetine compared to fluoxetine and escitalopram (SSRIs) as well as duloxetine (an SNRI), which were not active in these animal models. While animal studies may not ... and more »
The Pharma Letter Specifically, declines from baseline in MADRS total score ±standard error [SE] at week eight were -12.83(±0.834), -14.30(±0.89), -15.57(±0.880), -16.90(±0.884), respectively for placebo (n=161), vortioxetine 20 mg (p=.023, n=147), and duloxetine 60 mg ...
GlobeNewswire (press release) The preclinical data presented at the conference also show a different profile of vortioxetine compared to fluoxetine and escitalopram (SSRIs) as well as duloxetine (an SNRI), which were not active in these animal models. While animal studies may not ... and more »
Medscape In the first US study, 614 adults between the ages of 18 and 75 years with MDD were randomly assigned to receive daily 20 mg of vortioxetine (n = 154), 15 mg of...
pharmabiz.com Two studies included an established depression therapy, duloxetine , as an active reference arm that validated the studies and confirmed “assay sensitivity”. The four studies were also conducted to assess and provide further information on vortioxetine ...
